These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 8621166)
1. The pruritus of cholestasis is relieved by an opiate antagonist: is this pruritus a centrally mediated phenomenon? Heathcote J Hepatology; 1996 May; 23(5):1280-2. PubMed ID: 8621166 [No Abstract] [Full Text] [Related]
2. The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids. Bergasa NV; Jones EA Gastroenterology; 1995 May; 108(5):1582-8. PubMed ID: 7729651 [No Abstract] [Full Text] [Related]
3. Opioid antagonist for pruritus of cholestasis unmasking bony metastases. Lonsdale-Eccles AA; Carmichael AJ Acta Derm Venereol; 2009; 89(1):90. PubMed ID: 19197552 [No Abstract] [Full Text] [Related]
4. Management of the pruritus of cholestasis: potential role of opiate antagonists. Bergasa NV; Jones EA Am J Gastroenterol; 1991 Oct; 86(10):1404-12. PubMed ID: 1928030 [No Abstract] [Full Text] [Related]
5. Opiate receptor antagonists for treatment of severe pruritus associated with advanced cholestatic liver disease. Kumar N; Garg N; Bailey A J Palliat Med; 2013 Feb; 16(2):122-3. PubMed ID: 23391399 [No Abstract] [Full Text] [Related]
6. Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated. Nelson L; Vergnolle N; D'Mello C; Chapman K; Le T; Swain MG J Hepatol; 2006 Jun; 44(6):1141-9. PubMed ID: 16466825 [TBL] [Abstract][Full Text] [Related]
7. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. Jones EA; Neuberger J; Bergasa NV QJM; 2002 Aug; 95(8):547-52. PubMed ID: 12145394 [TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis and treatment of pruritus in patients with cholestasis]. Schirrmacher S; Blumenstein I; Stein J Z Gastroenterol; 2003 Mar; 41(3):259-62. PubMed ID: 12664347 [TBL] [Abstract][Full Text] [Related]
9. The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these years. Bergasa NV Med Hypotheses; 2018 Jan; 110():86-89. PubMed ID: 29317077 [TBL] [Abstract][Full Text] [Related]
10. Re: Pruritus in patients with advanced cancer. Prommer E J Pain Symptom Manage; 2005 Sep; 30(3):201-2. PubMed ID: 16183000 [No Abstract] [Full Text] [Related]
11. Treatment of pruritus caused by cholestasis with opioid antagonists. Jones EA; Zylicz Z J Palliat Med; 2005 Dec; 8(6):1290-4. PubMed ID: 16351546 [No Abstract] [Full Text] [Related]
12. Naloxone for intractable pruritus? Zuckerman E; Schar M; Korula J Am J Gastroenterol; 1997 Jan; 92(1):183-4. PubMed ID: 8995978 [No Abstract] [Full Text] [Related]
13. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus. Tandon P; Rowe BH; Vandermeer B; Bain VG Am J Gastroenterol; 2007 Jul; 102(7):1528-36. PubMed ID: 17403073 [TBL] [Abstract][Full Text] [Related]
14. Severe pruritus of cholestasis in disseminated cancer: developing a rational treatment strategy. A case report. Zylicz Z; Stork N; Krajnik M J Pain Symptom Manage; 2005 Jan; 29(1):100-3. PubMed ID: 15652443 [TBL] [Abstract][Full Text] [Related]
15. The pruritus of cholestasis and the opioid system. Jones EA; Bergasa NV JAMA; 1992 Dec; 268(23):3359-62. PubMed ID: 1333541 [No Abstract] [Full Text] [Related]
16. The pruritus of cholestasis. Bergasa NV Semin Dermatol; 1995 Dec; 14(4):302-12. PubMed ID: 8679436 [TBL] [Abstract][Full Text] [Related]
17. Naltrexone: a case report of pruritus from an antipruritic. Sullivan JR; Watson A Australas J Dermatol; 1997 Nov; 38(4):196-8. PubMed ID: 9431714 [TBL] [Abstract][Full Text] [Related]
18. Rationale for treating pruritus complicating chronic liver disease with opiate antagonists. Jones EA Curr Gastroenterol Rep; 2004 Apr; 6(2):87-8. PubMed ID: 15191684 [No Abstract] [Full Text] [Related]
20. Pruritus and fatigue associated with liver disease: is there a role for ondansetron? Jones EA Expert Opin Pharmacother; 2008 Mar; 9(4):645-51. PubMed ID: 18312165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]